AMY MCLEAN: Open Payments
NPI 1356796874 · SALEM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 62 payments from 12 companies in 2025. Trend: 2023 $741 · 2024 $576 · 2025 $1,115
Food & beverage: $1,115
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $337 |
| Otsuka America Pharmaceutical, Inc. | 13 | $160 |
| Alkermes, Inc. | 6 | $118 |
| Janssen Pharmaceuticals, Inc | 1 | $95 |
| Vanda Pharmaceuticals Inc. | 3 | $84 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Collegium Pharmaceutical, Inc. | 5 | $75 |
| Supernus Pharmaceuticals, Inc. | 3 | $63 |
| Novo Nordisk Inc | 1 | $34 |
| ABBVIE INC. | 2 | $30 |
Products named: CAPLYTA, ARISTADA, REXULTI, SPRAVATO, FANAPT, Auvelity, Jornay PM, Qelbree.
Industry payments across IL — which companies pay providers there.
